Key Insights

Highlights

Treatment Research

5 treatments under study, led by Ifosfamide

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02393157Phase 2Recruiting

Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL

Showing all 1 trials

Research Network

Common Treatments

  • Ifosfamide1
  • Liposomal Arac1
  • Carboplatin1
  • Etoposide1
  • Obinutuzumab1

Active Sponsors

  • New York Medical College1
  • Roswell Park Cancer Institute1

Top Investigators

Related Conditions

  • Primary Mediastinal Bcell Lymphoma1
  • Diffuse Large Bcell Lymphoma1
  • Follicular Lymphoma Grade Iii1
  • Nonhodgkin Lymphoma1
  • Burkitt Lymphoma1

Activity Timeline